Market Closed -
NSE India S.E.
07:43:54 2024-06-28 am EDT
|
5-day change
|
1st Jan Change
|
465
INR
|
-1.67%
|
|
-9.34%
|
-21.11%
|
Fiscal Period: Marzo |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
12,290
|
8,378
|
5,270
|
8,578
|
10,524
|
6,139
|
Enterprise Value (EV)
1 |
11,665
|
7,964
|
4,520
|
8,245
|
10,364
|
5,750
|
P/E ratio
|
56.9
x
|
45.1
x
|
10.4
x
|
3.9
x
|
24.3
x
|
32
x
|
Yield
|
0.94%
|
2.76%
|
4.82%
|
17.5%
|
-
|
-
|
Capitalization / Revenue
|
1.21
x
|
0.81
x
|
0.7
x
|
1.17
x
|
1.25
x
|
0.8
x
|
EV / Revenue
|
1.15
x
|
0.77
x
|
0.6
x
|
1.13
x
|
1.23
x
|
0.75
x
|
EV / EBITDA
|
22.7
x
|
12.7
x
|
6.88
x
|
9.54
x
|
16.7
x
|
9.29
x
|
EV / FCF
|
-71
x
|
79.6
x
|
-7.9
x
|
4.59
x
|
155
x
|
40.4
x
|
FCF Yield
|
-1.41%
|
1.26%
|
-12.7%
|
21.8%
|
0.64%
|
2.47%
|
Price to Book
|
1.97
x
|
1.36
x
|
0.81
x
|
2.11
x
|
2.54
x
|
1.42
x
|
Nbr of stocks (in thousands)
|
23,082
|
23,082
|
23,082
|
23,082
|
23,082
|
23,082
|
Reference price
2 |
532.4
|
363.0
|
228.3
|
371.6
|
456.0
|
266.0
|
Announcement Date
|
7/7/18
|
7/19/19
|
7/25/20
|
7/13/21
|
7/29/22
|
9/1/23
|
Fiscal Period: Marzo |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
10,136
|
10,281
|
7,573
|
7,308
|
8,395
|
7,664
|
EBITDA
1 |
514.7
|
624.7
|
657.1
|
864.3
|
618.9
|
619.3
|
EBIT
1 |
137.5
|
250.4
|
309.1
|
582.1
|
418.6
|
417.1
|
Operating Margin
|
1.36%
|
2.44%
|
4.08%
|
7.97%
|
4.99%
|
5.44%
|
Earnings before Tax (EBT)
1 |
334.1
|
301.4
|
342.9
|
3,129
|
495
|
399.7
|
Net income
1 |
216
|
185.6
|
507.1
|
2,198
|
433.2
|
191.8
|
Net margin
|
2.13%
|
1.81%
|
6.7%
|
30.07%
|
5.16%
|
2.5%
|
EPS
2 |
9.358
|
8.041
|
21.97
|
95.21
|
18.77
|
8.309
|
Free Cash Flow
1 |
-164.3
|
100.1
|
-572.3
|
1,797
|
66.73
|
142.3
|
FCF margin
|
-1.62%
|
0.97%
|
-7.56%
|
24.59%
|
0.79%
|
1.86%
|
FCF Conversion (EBITDA)
|
-
|
16.03%
|
-
|
207.88%
|
10.78%
|
22.97%
|
FCF Conversion (Net income)
|
-
|
53.94%
|
-
|
81.76%
|
15.4%
|
74.17%
|
Dividend per Share
2 |
5.000
|
10.00
|
11.00
|
65.00
|
-
|
-
|
Announcement Date
|
7/7/18
|
7/19/19
|
7/25/20
|
7/13/21
|
7/29/22
|
9/1/23
|
Fiscal Period: Marzo |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
625
|
413
|
750
|
334
|
160
|
388
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-164
|
100
|
-572
|
1,797
|
66.7
|
142
|
ROE (net income / shareholders' equity)
|
3.33%
|
2.99%
|
2.93%
|
41.3%
|
10.6%
|
4.53%
|
ROA (Net income/ Total Assets)
|
0.94%
|
1.75%
|
2.1%
|
4.57%
|
4.07%
|
4.02%
|
Assets
1 |
22,945
|
10,597
|
24,118
|
48,100
|
10,640
|
4,774
|
Book Value Per Share
2 |
271.0
|
267.0
|
282.0
|
176.0
|
179.0
|
187.0
|
Cash Flow per Share
2 |
8.730
|
12.20
|
11.20
|
10.50
|
3.000
|
16.80
|
Capex
1 |
291
|
324
|
246
|
95.8
|
201
|
163
|
Capex / Sales
|
2.87%
|
3.15%
|
3.25%
|
1.31%
|
2.4%
|
2.13%
|
Announcement Date
|
7/7/18
|
7/19/19
|
7/25/20
|
7/13/21
|
7/29/22
|
9/1/23
|
|
1st Jan change
|
Capi.
|
---|
| +19.99% | 67.97B | | -6.03% | 45.92B | | +22.27% | 43.74B | | +33.20% | 28.16B | | +8.15% | 19.17B | | +14.71% | 17.12B | | -13.18% | 14.73B | | -27.99% | 14.52B | | -32.33% | 11.64B |
Other Specialty Chemicals
|